April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Addition of αA-Crystallin Sequence 163-173 to αA-Mini-chaperone, DFVIFLDVKHFSPEDLT Alters The Conformation But Retains The Chaperone Activity
Author Affiliations & Notes
  • Krishna Sharma
    Ophthalmology and Biochemistry, University of Missouri, Columbia, MO
  • Raju Murugesan
    Ophthalmology, University of Missouri, Columbia, MO
  • Puttur Santhoshkumar
    Ophthalmology, University of Missouri, Columbia, MO
  • Footnotes
    Commercial Relationships Krishna Sharma, None; Raju Murugesan, None; Puttur Santhoshkumar, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5725. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Krishna Sharma, Raju Murugesan, Puttur Santhoshkumar; Addition of αA-Crystallin Sequence 163-173 to αA-Mini-chaperone, DFVIFLDVKHFSPEDLT Alters The Conformation But Retains The Chaperone Activity. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5725.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: It has been shown that mini-chaperone, a peptide representing the chaperone binding site in αA-crystallin prevents destabilized protein aggregation. It was also shown that mini-chaperone forms amyloid fibrils. The present study was undertaken to improve mini-chaperone stability while preserving its anti-aggregation activity by fusing the flexible and solvent exposed C-terminal 163-173 region of αA-crystallin to the mini-chaperone, DFVIFLDVKHFSPEDLTVK to get a chimeric peptide (CP1) chaperone and to characterize the same

Methods: Circular dichroism, TEM, Thioflavin T binding assays were used to characterize the peptide chaperone. The chaperone activity of the CP1 was measured with ADH, CS and αLA as client proteins. ARPE-19 cells were used to determine the anti-oxidation/anti-apoptotic activity.

Results: Circular dichroism studies showed that unlike the beta sheet structure shown by mini-chaperone the CP-1 peptide exhibited random structure. Examination of CP-1 peptide incubated in a shaker at 37o C for 72 hrs under TEM did not show amyloid fibrils whereas theα A-mini-chaperone showed distinct fibrils. Consistent with TEM observation, Thioflavin T binding assays showed increased dye binding with mini-chaperone incubated at 37oC and subjected to shaking but not with CP1 peptide incubated under similar conditions. The chaperone activity of the CP1 peptide was comparable to that of mini-chaperone when denaturing ADH, CS and αLA were used as client proteins. Transduction of both peptide chaperones to ARPE cells showed no cytotoxic effects. The anti-oxidation assay involving H2O2 treatment of ARPE cells revealed that both original mini-chaperone and CP1 peptide have comparable cytoprotective activity against hydrogen peroxide induced oxidative damage.

Conclusions: The present study shows that addition of C-terminal sequence 163-173 of αA-crystallin to αA-mini-chaperone influences the conformation of αA-mini-chaperone without affecting its chaperone function or cytoprotection activity.

Keywords: 450 chaperones • 488 crystallins • 634 oxidation/oxidative or free radical damage  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.